Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "MonumenTAL-1 Study - Talquetamab in Pts With R/R MM Previously Exposed to T-Cell Redirecting Therapies"
By
Insights from 2023 ASH Annual Meeting
FEATURING
Andrzej Jakubowiak
By
Insights from 2023 ASH Annual Meeting
FEATURING
Andrzej Jakubowiak
Login to view comments.
Click here to Login